Meet Proteona at BioRN 2020: 20 Nov.

Precision Technologies 4 Life

Meet Proteona at the BioRN Annual Conference 2020

Innovative AI-driven genomic and proteomic analysis platform for improving cell therapy and immuno-oncology

Proteona will attend the BioRN Annual Conference 2020, taking place on Friday, the 20th of November 2020.

This year’s conference, focusing on the topic of “Precision Technologies 4 Life”, will be delivered virtually. It will feature keynote presentations on using molecular profiling to improve disease detection and precision medicine. Register now to schedule one-to-one meetings with Proteona.

Check out the BioRN 2020 conference program here!

Follow Proteona on LinkedIn

For media queries, please contact:

Dr Andreas Schmidt

About Proteona

Proteona Pte. Ltd. is a biomedical company in Singapore, Germany, and the US that is pioneering the use of single cell proteogenomics to improve clinical outcomes in cancer. Using a combination of innovative single cell assays and AI-assisted bioinformatics, Proteona provides a comprehensive sample to answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research (A*STAR). Proteona is leading an international alliance to develop neutralizing antibodies against coronaviruses including SARS-CoV-2. In addition, Proteona supports partners developing COVID-19 therapies and vaccines by providing single cell immune profiling services.